AIMS/HYPOTHESIS: A key unanswered question in type 1 diabetes is whether beta cells initiate their own destruction or are victims of an aberrant immune response (beta cell suicide or homicide?). To investigate this, we assessed islet autoantibodies in individuals with congenital beta cell defects causing neonatal diabetes mellitus (NDM). METHODS: We measured autoantibodies to GAD (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) in 242 individuals with NDM (median age diagnosed 1.8 months [IQR 0.39-2.9 months]; median age collected 4.6 months [IQR 1.8-27.6 months]; median diabetes duration 2 months [IQR 0.6-23 months]), including 75 whose NDM resulted from severe beta cell endoplasmic reticulum (ER) stress. As a control cohort ...
Aims/hypothesis: Genetic studies show coupling of genes affecting beta cell function to type 1 diabe...
AIMS/HYPOTHESIS: The aim of this study was to explore the utility of islet autoantibody (IAb) levels...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...
AIMS/HYPOTHESIS: A key unanswered question in type 1 diabetes is whether beta cells initiate their o...
AIMS/HYPOTHESIS: The reason for the observed lower rate of islet autoantibody positivity in clinicia...
AIMS/HYPOTHESIS: Autoantibodies that precede type 1 diabetes frequently develop in early childhood a...
It is increasingly appreciated that the pathogenic mechanisms of type 1 diabetes involve both the au...
CONTEXT: The importance of the autoantibody level at diagnosis of type 1 diabetes is not clear. OBJE...
Published onlineJOURNAL ARTICLEAIMS/HYPOTHESIS: This study aimed to determine the frequency of resid...
Background: Autoantibodies (AAbs) against islet autoantigens (AAgs) are used for type 1 diabetes (T1...
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis t...
Aims/hypothesis: The aim of this study was to explore the utility of islet autoantibody (IAb) levels...
BACKGROUND: Individuals with multiple islet autoantibodies are at increased risk for clinical type 1...
AIMS/HYPOTHESIS: Islet autoantibody-positive children progress to type 1 diabetes at variable rates....
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
Aims/hypothesis: Genetic studies show coupling of genes affecting beta cell function to type 1 diabe...
AIMS/HYPOTHESIS: The aim of this study was to explore the utility of islet autoantibody (IAb) levels...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...
AIMS/HYPOTHESIS: A key unanswered question in type 1 diabetes is whether beta cells initiate their o...
AIMS/HYPOTHESIS: The reason for the observed lower rate of islet autoantibody positivity in clinicia...
AIMS/HYPOTHESIS: Autoantibodies that precede type 1 diabetes frequently develop in early childhood a...
It is increasingly appreciated that the pathogenic mechanisms of type 1 diabetes involve both the au...
CONTEXT: The importance of the autoantibody level at diagnosis of type 1 diabetes is not clear. OBJE...
Published onlineJOURNAL ARTICLEAIMS/HYPOTHESIS: This study aimed to determine the frequency of resid...
Background: Autoantibodies (AAbs) against islet autoantigens (AAgs) are used for type 1 diabetes (T1...
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis t...
Aims/hypothesis: The aim of this study was to explore the utility of islet autoantibody (IAb) levels...
BACKGROUND: Individuals with multiple islet autoantibodies are at increased risk for clinical type 1...
AIMS/HYPOTHESIS: Islet autoantibody-positive children progress to type 1 diabetes at variable rates....
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
Aims/hypothesis: Genetic studies show coupling of genes affecting beta cell function to type 1 diabe...
AIMS/HYPOTHESIS: The aim of this study was to explore the utility of islet autoantibody (IAb) levels...
Background: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable ...